Copyright © 2007, European Society of Cardiology
Overexpression of histidine-rich Ca-binding protein protects against ischemia/reperfusion-induced cardiac injury
aDepartment of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, OH 45267-0575, USA
bDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China
cMolecular Biology Division, Center for Basic Research, Foundation for Biomedical Research of the Academy of Athens, Athens 11527, Greece
* Corresponding author. Department of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH, 5267-0575, USA. Tel.: +1 513 558 2327; fax: +1 513 558 2269. litsa.kranias{at}uc.edu
Objective The histidine-rich Ca-binding protein (HRC) is a Ca-storage protein in cardiac sarcoplasmic reticulum. Recent transgenic studies revealed that this protein inhibits the maximal rates of sarcoplasmic reticulum Ca-transport, leading to cardiac dysfunction. In view of the role of sarcoplasmic reticulum Ca-cycling in myocardial ischemia/reperfusion injury, we designed this study to gain further insight into the role of HRC during ischemia/reperfusion.
Methods and results The transgenic mouse model with cardiac-specific overexpression of HRC was utilized and cardiac contractile parameters were assessed before and after ischemia/reperfusion injury by Langendorff perfusion. After a 20-min stabilization period, the hearts were subjected to 40 min of global ischemia, followed by 60 min of reperfusion. We found that although transgenic (TG) hearts showed depressed cardiac function (25%) compared to wild types (WTs) at baseline, they exhibited better recovery of left ventricular developed pressure (86.6±2.6% in TGs vs. 58.3±4.0% in WTs of pre-ischemic values, P<0.05) and higher rates of contraction and relaxation after ischemia/reperfusion than WTs. This improvement was accompanied by smaller infarcts (23.1±1.7% in TGs vs. 41.1±2.5% in WTs of infarct region-to-risk region ratio, P<0.05) and lower creatine kinase release. Notably, the extent of apoptotic cell death was significantly attenuated, as evidenced by decreased DNA fragmentation, upregulation of the antiapoptotic protein Bcl-2, and downregulation of the active caspases (3, 9 and 12) following ischemia/reperfusion in TG hearts, compared with WTs. Extension of these studies to an in vivo model of 30-min myocardial ischemia, via coronary artery occlusion, followed by 24-h reperfusion, showed that the infarct region-to-risk region ratio was 9±0.9% in TGs, compared with 20.4±2.9% in WTs (P<0.05).
Conclusions Our findings suggest that increased cardiac HRC expression protects against ischemia/reperfusion injury in the heart, resulting in improved recovery of function and reduced infarction.
KEYWORDS Histidine-rich Ca-binding protein; Transgenic; Ischemia/reperfusion; Apoptosis; Ca cycling
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  T. J. Pritchard and E. G. Kranias Junctin and the histidine-rich Ca2+ binding protein: potential roles in heart failure and arrhythmogenesis J. Physiol., July 1, 2009; 587(13): 3125 - 3133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Nicolaou, P. Rodriguez, X. Ren, X. Zhou, J. Qian, S. Sadayappan, B. Mitton, A. Pathak, J. Robbins, R. J. Hajjar, et al. Inducible Expression of Active Protein Phosphatase-1 Inhibitor-1 Enhances Basal Cardiac Function and Protects Against Ischemia/Reperfusion Injury Circ. Res., April 24, 2009; 104(8): 1012 - 1020. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tanno and T. Miura Protecting ischemic hearts by modulation of SR calcium handling Cardiovasc Res, August 1, 2007; 75(3): 453 - 454. [Full Text] [PDF]
|
|